The fate and function of therapeutic antiaddiction monoclonal antibodies across the reproductive cycle of rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 336, Issue 2, 2011, Pages 414-422

  Hubbard, Jonathan J ^a   Laurenzana, Elizabeth M ^a,b   Williams, D Keith ^a   Gentry, W Brooks ^a   Owens, S Michael ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G1; IMMUNOGLOBULIN KAPPA CHAIN; METHAMPHETAMINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 6B5; MONOCLONAL ANTIBODY 6H4; PHENCYCLIDINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; AREA UNDER THE CURVE; ARTICLE; BIRTH; BLOOD PLACENTA BARRIER; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MEGADOSE; FEMALE; LACTATION; LOW DRUG DOSE; NONHUMAN; OVARY CYCLE; PRIORITY JOURNAL; PUERPERIUM; RAT; SECOND TRIMESTER PREGNANCY; SYNCYTIOTROPHOBLAST; THIRD TRIMESTER PREGNANCY;

ANIMALS; ANTIBODIES, MONOCLONAL; FEMALE; FETUS; MATERNAL-FETAL EXCHANGE; METHAMPHETAMINE; PHENCYCLIDINE; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE-RELATED DISORDERS;

EID: 78650665531     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.175083     Document Type: Article

References (40)

1. Ali SF, Ahmad G, Slikker W Jr, and Bondy SC (1989) Effects of gestational exposure to phencyclidine: distribution and neurochemical alterations in maternal and fetal brain. Neurotoxicology 10:383-392. (Pubitemid 20084625)
2. Arizono H, Ishii S, Nagao T, Kudo S, Sasaki S, Kondo S, and Kiyoki M (1994) Pharmacokinetics of a new human monoclonal antibody against cytomegalovirus. First communication: plasma concentration, distribution, metabolism and excretion of the new monoclonal antibody, regavirumab after intravenous administration in rats and rabbits. Arzneimittelforschung 44:890-898. (Pubitemid 24312419)
3. Bazin-Redureau MI, Renard CB, and Scherrmann JM (1997) Pharmacokinetics of heterologous and homologous immunoglobulin G, F(ab′)2 and Fab after intravenous administration in the rat. J Pharm Pharmacol 49:277-281.
4. Benster B and Wood EJ (1970) Immunoglobulin levels in normal pregnancy and pregnancy complicated by hypertension. J Obstet Gynaecol Br Commonw 77:518-522.
5. Bichler J, Schondorfer G, Pabst G, and Andresen I (2003) Pharmacokinetics of anti-D IgG in pregnant RhD-negative women. BJOG 110:39-45.
6. Bichler J, Spycher MO, Amstutz HP, Andresen I, Gaede K, and Miescher S (2004) Pharmacokinetics and safety of recombinant anti-RhD in healthy RhD-negative male volunteers. Transfus Med 14:165-171.
7. Brambell FW, Hemmings WA, and Morris IG (1964) A theoretical model of γ-globulin catabolism. Nature 203:1352-1354.
8. de Rijk EP, van Esch E, and Flik G (2002) Pregnancy dating in the rat: placental morphology and maternal blood parameters. Toxicol Pathol 30:271-282.
9. Dowell RT and Kauer CD (1997) Maternal hemodynamics and uteroplacental blood flow throughout gestation in conscious rats. Methods Find Exp Clin Pharmacol 19:613-625.
10. Firan M, Bawdon R, Radu C, Ober RJ, Eaken D, Antohe F, Ghetie V, and Ward ES (2001) The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humans. Int Immunol 13:993-1002.
11. Garg A and Balthasar JP (2007) Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice. J Pharmacokinetics Pharmacodynamics 34:687-709. (Pubitemid 47477039)
12. Glantz JC and Woods JR Jr. (1993) Cocaine, heroin, and phencyclidine: obstetric perspectives. Clin Obstet Gynecol 36:279-301.
13. Hardin JS, Wessinger WD, Proksch JW, and Owens SM (1998) Pharmacodynamics of a monoclonal antiphencyclidine Fab with broad selectivity for phencyclidine-like drugs. J Pharmacol Exp Ther 285:1113-1122.
14. Hendrickson H, Laurenzana E, and Owens SM (2006) Quantitative determination of total methamphetamine and active metabolites in rat tissue by liquid chromatography with tandem mass spectrometric detection. AAPS J 8:E709-E717.
15. Hendrickson HP, Whaley EC, and Owens SM (2005) A validated liquid chromatographic/ tandem mass spectrometric method for the determination of phencyclidine in microliter samples of rat serum. J Mass Spectrom 40:19-24.
16. Ishii S, Arizono H, Nagao T, Kudo S, Kondo S, and Kiyoki M (1994) Pharmacokinetics of a new human monoclonal antibody against cytomegalovirus. Second communication: distribution and elimination of the new monoclonal antibody, regavirumab after repeated administration in rats, and placental transfer and milk-passage study after single administration to pregnant and lactating rats. Arzneimittelforschung 44:899-908.
17. Israel EJ, Wilsker DF, Hayes KC, Schoenfeld D, and Simister NE (1996) Increased clearance of IgG in mice that lack β2-microglobulin: possible protective role of FcRn. Immunology 89:573-578.
18. Junghans RP and Anderson CL (1996) The protection receptor for IgG catabolism is the β2-microglobulin-containing neonatal intestinal transport receptor. Proc Natl Acad Sci USA 93:5512-5516. (Pubitemid 126585544)
19. Kane SV and Acquah LA (2009) Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy. Am J Gastroenterol 104:228-233.
20. Kantak KM, Collins SL, Lipman EG, Bond J, Giovanoni K, and Fox BS (2000) Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model. Psychopharmacology 148:251-262.
21. Keyler DE, Dufek MB, Calvin AD, Bramwell TJ, LeSage MG, Raphael DE, Ross CA, Le CT, and Pentel PR (2005a) Reduced nicotine distribution from mother to fetal brain in rats vaccinated against nicotine: time course and influence of nicotine dosing regimen. Biochem Pharmacol 69:1385-1395.
22. Keyler DE, Lesage MG, Dufek MB, and Pentel PR (2006) Changes in maternal and fetal nicotine distribution after maternal administration of monoclonal nicotinespecific antibody to rats. Int Immunopharmacol 6:1665-1672.
23. Keyler DE, Roiko SA, Benlhabib E, LeSage MG, St Peter JV, Stewart S, Fuller S, Le CT, and Pentel PR (2005b) Monoclonal nicotine-specific antibodies reduce nicotine distribution to brain in rats: dose- and affinity-response relationships. Drug Metab Dispos 33:1056-1061.
24. Laurenzana EM, Byrnes-Blake KA, Milesi-Hallé A, Gentry WB, Williams DK, and Owens SM (2003a) Use of anti-(+)-methamphetamine monoclonal antibody to significantly alter (+)-methamphetamine and (+)-amphetamine disposition in rats. Drug Metab Dispos 31:1320-1326.
25. Laurenzana EM, Gunnell MG, Gentry WB, and Owens SM (2003b) Treatment of adverse effects of excessive phencyclidine exposure in rats with a minimal dose of monoclonal antibody. J Pharmacol Exp Ther 306:1092-1098.
26. Lobo ED, Hansen RJ, and Balthasar JP (2004) Antibody pharmacokinetics and pharmacodynamics. J Pharm Sci 93:2645-2668.
27. Lu W, Zhao Z, Zhao Y, Yu S, Zhao Y, Fan B, Kacskovics I, Hammarström L, and Li N (2007) Over-expression of the bovine FcRn in the mammary gland results in increased IgG levels in both milk and serum of transgenic mice. Immunology 122:401-408. (Pubitemid 47556477)
28. McClurkan MB, Valentine JL, Arnold L, and Owens SM (1993) Disposition of a monoclonal anti-phencyclidine Fab fragment of immunoglobulin G in rats. J Pharmacol Exp Ther 266:1439-1445.
29. Mir O, Berveiller P, and Pons G (2007) Trastuzumab-mechanism of action and use. N Engl J Med 357:1664-1665; author reply 1665-1666.
30. Nekhayeva IA, Nanovskaya TN, Pentel PR, Keyler DE, Hankins GD, and Ahmed MS (2005) Effects of nicotine-specific antibodies, Nic311 and Nic-IgG, on the transfer of nicotine across the human placenta. Biochem Pharmacol 70:1664-1672.
31. Østensen M and Förger F (2009) Management of RA medications in pregnant patients. Nat Rev Rheumatol 5:382-390.
32. Pentel PR, Dufek MB, Roiko SA, Lesage MG, and Keyler DE (2006) Differential effects of passive immunization with nicotine-specific antibodies on the acute and chronic distribution of nicotine to brain in rats. J Pharmacol Exp Ther 317:660-666.
33. Peterson EC, Laurenzana EM, Atchley WT, Hendrickson HP, and Owens SM (2008) Development and preclinical testing of a high-affinity single-chain antibody against (+)-methamphetamine. J Pharmacol Exp Ther 325:124-133.
34. Pitas G, Laurenzana EM, Williams DK, Owens SM, and Gentry WB (2006) Antiphencyclidine monoclonal antibody binding capacity is not the only determinant of effectiveness, disproving the concept that antibody capacity is easily surmounted. Drug Metab Dispos 34:906-912.
35. Proksch JW, Gentry WB, and Owens SM (2000) Anti-phencyclidine monoclonal antibodies provide long-term reductions in brain phencyclidine concentrations during chronic phencyclidine administration in rats. J Pharmacol Exp Ther 292: 831-837.
36. Rivière GJ, Gentry WB, and Owens SM (2000) Disposition of methamphetamine and its metabolite amphetamine in brain and other tissues in rats after intravenous administration. J Pharmacol Exp Ther 292:1042-1047.
37. Rowland M and Tozer TN (1995) Clinical Pharmacokinetics: Concepts and Applications, Williams & Wilkins, Baltimore.
38. Simister NE (2003) Placental transport of immunoglobulin G. Vaccine 21:3365-3369.
39. Wani MA, Haynes LD, Kim J, Bronson CL, Chaudhury C, Mohanty S, Waldmann TA, Robinson JM, and Anderson CL (2006) Familial hypercatabolic hypoproteinemia caused by deficiency of the neonatal Fc receptor, FcRn, due to a mutant β2-microglobulin gene. Proc Natl Acad Sci USA 103:5084-5089.
40. White SJ, Laurenzana EM, Gentry WB, Hendrickson HP, Williams DK, Ward KW, and Owens SM (2009) Vulnerability to (+)-methamphetamine effects and the relationship to drug disposition in pregnant rats during chronic infusion. Toxicol Sci 111:27-36.